Several hypoglycemic medications are commonly used for T2DM, including metformin, gliclazide, glucagon-like peptide-1 (GLP-1) analogues, and dipeptidyl peptidase-4 (DPP-4) inhibitors. Here, GLP1R is linked to type 2 diabetes mellitus.